Echenique-Elizondo Miguel, Amondarain José Antonio, Vidaur Fernando, Olalla Carmen, Aribe Fernando, Garrido Adolfo, Molina José, Rodrigo María Teresa
Departamento de Cirugía, Universidad del País Vasco, San Sebastián (Guipúzcoa), España.
Cir Esp. 2007 Sep;82(3):155-60. doi: 10.1016/s0009-739x(07)71691-3.
In the setting of total parathyroidectomy (TPT) and parathyroid transplantation (PTx) for renal hyperparathyroidism (RHP), we evaluated long-term parathyroid graft function after subcutaneous presternal transplantation (SCPTx).
Parathyroid glands are surrounded by fatty tissue. Therefore, we postulated that subcutaneous implantation of parathyroid tissue after TPT for RHP could be at least as effective as intramuscular grafting and would avoid the complications of the latter technique.
We performed a study in a university hospital and its dialysis unit.
Prospective open efficacy study of a postoperative diagnostic monitoring method of intact parathyroid hormone (iPTH) in a cohort of surgical patients without loss to follow-up.
Thirty-five patients (19 women and 16 men) underwent TPT and SCPTx for RHP at the Department of General Surgery and Department of Nephrology, Donostia Hospital, San Sebastián, Gipuzkoa, Spain, from January 2002 to December 2005. Follow-up ranged from 6 to 42 months (mean, 15.4 months). Graft function was evaluated by measurement of plasma iPTH levels before surgery and 24 hours and 1, 3, 5, 15, 30, 60, 100 and 150 weeks after surgery. Reference values for PTH in our laboratory were 20-65 pg/mL.
The mean preoperative iPTH values were 1245 +/- 367.9 pg/mL (mean +/- SD) (range, 493-2160). After TPT and SCPTx, iPTH levels became undetectable in all patients at 24 hours. A value of 50 pg/mL was established as the criterion for adequate parathyroid graft function. The following values were obtained: 15.54 +/- 10.61 pg/mL (mean +/- SD) (range, 6-44) after 1 week, 57.2 +/- 1.9 pg/mL (mean +/- SD) (range, 43-74) after 5 weeks, 64.21 +/- 9.73 pg/mL (mean +/- SD) (range, 11.3-89) after 15 weeks, 75.12 +/- 9.05 pg/mL (mean +/- SD) (range, 24.6-104.2) after 30 weeks, 101.63 +/- 19.85 pg/mL (mean +/- SD) (range, 65-143) after 60 weeks, 121.63 +/- 27.85 pg/mL (mean +/- SD) (range, 62-179) after 100 weeks, 63 +/- 19.85 pg/mL (mean +/- SD) (range, 68-723) after 150 weeks and 102 +/- 18.65 pg/mL (mean +/- SD) (range, 68-113) after 200 weeks. The prevalence of hypoparathyroidism (serum iPTH level of < 20 pg/mL with a normal or low serum calcium concentration) was 2 out of 35 patients (5.71%) by week 60, with recovery of normal values by week 100. Graft-related recurrence occurred in one out of 35 patients (2.85%).
SCPTx after TPT and PTx for secondary RHP is an adequate method to replace muscular forearm parathyroid transplantation and avoid its complications. The functional results of TPT and SCPTx compare favorably with published data on other surgical techniques proposed for the treatment of RHP. Long-term follow-up of this series is currently being performed.
在因肾性甲状旁腺功能亢进(RHP)而行甲状旁腺全切除术(TPT)及甲状旁腺移植术(PTx)的背景下,我们评估了胸骨前皮下移植(SCPTx)后甲状旁腺移植物的长期功能。
甲状旁腺被脂肪组织所包围。因此,我们推测对于RHP患者,TPT后甲状旁腺组织的皮下植入至少与肌肉内移植同样有效,且能避免后者的并发症。
我们在一所大学医院及其透析科开展了一项研究。
对一组无失访的手术患者进行术后完整甲状旁腺激素(iPTH)诊断监测方法的前瞻性开放疗效研究。
2002年1月至2005年12月期间,西班牙吉普斯夸省圣塞瓦斯蒂安德诺斯蒂亚医院普通外科和肾病科的35例患者(19例女性和16例男性)因RHP接受了TPT及SCPTx。随访时间为6至42个月(平均15.4个月)。通过测量术前及术后24小时、1、3、5、15、30、60、100和150周的血浆iPTH水平来评估移植物功能。我们实验室PTH的参考值为20 - 65 pg/mL。
术前iPTH平均水平为1245 ± 367.9 pg/mL(平均值 ± 标准差)(范围493 - 2160)。TPT及SCPTx后,所有患者在术后24小时iPTH水平均不可测。将50 pg/mL的值确定为甲状旁腺移植物功能良好的标准。术后获得以下值:术后1周为15.54 ± 10.61 pg/mL(平均值 ± 标准差)(范围6 - 44),术后5周为57.2 ± 1.9 pg/mL(平均值 ± 标准差)(范围43 - 74),术后15周为64.21 ± 9.73 pg/mL(平均值 ± 标准差)(范围11.3 - 89),术后30周为75.12 ± 9.05 pg/mL(平均值 ± 标准差)(范围24.6 - 104.2),术后60周为101.63 ± 19.85 pg/mL(平均值 ± 标准差)(范围65 - 143),术后100周为121.63 ± 27.85 pg/mL(平均值 ± 标准差)(范围62 - 179),术后150周为63 ± 19.85 pg/mL(平均值 ± 标准差)(范围68 - 723),术后200周为102 ± 18.65 pg/mL(平均值 ± 标准差)(范围68 - 113)。至第60周时,35例患者中有2例(5.71%)发生甲状旁腺功能减退(血清iPTH水平 < 20 pg/mL且血清钙浓度正常或降低),至第100周时恢复正常。35例患者中有1例(2.8%)发生移植物相关复发。
TPT及PTx治疗继发性RHP后行SCPTx是替代前臂肌肉甲状旁腺移植并避免其并发症的一种合适方法。TPT及SCPTx的功能结果与已发表的用于治疗RHP的其他手术技术的数据相比具有优势。目前正在对该系列进行长期随访。